Acceleron Pharma, Inc. (NASDAQ:XLRN) belongs to Healthcare sector. Its weekly performance is 6.24%. On last trading day company shares ended up $31.67. Acceleron Pharma, Inc. (NASDAQ:XLRN) distance from 50-day simple moving average (SMA50) is 0.91%. Zacks cut shares of Acceleron Pharma Inc. (NASDAQ:XLRN) from a hold rating to a sell rating in a report.
aTyr Pharma Inc. (NASDAQ:LIFE) shares decreased -7.66% in last trading session and ended the day at $17.96. LIFE return on assets is -149.10%. aTyr Pharma, Inc. (NASDAQ:LIFE) today announced the resignation of President and Chief Operating Officer Frederic Chereau to pursue other opportunities, effective immediately.
On 14 July, Manhattan Associates, Inc. (NASDAQ:MANH) shares moved up 1.48% and was closed at $62.39. MANH EPS growth in last 5 year was 43.10%. Manhattan Associates, Inc. (NASDAQ:MANH) year to date (YTD) performance is 53.22%. Cumberland-based Manhattan Associates Inc. (NASDAQ:MANH), will release its second quarter 2015 financial results on July 21 after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates’ senior management at 4:30 p.m.
Twitter Inc (NYSE:TWTR) belongs to Technology sector. Its net profit margin is -38.30% and weekly performance is 3.38%. On last trading day company shares ended up $36.72. Twitter Inc (NYSE:TWTR) distance from 50-day simple moving average (SMA50) is 1.37%. A report claiming that Twitter Inc. (NYSE:TWTR) received an offer to be acquired for $31 billion (roughly Rs. 1,96,572 crores) attributed to Bloomberg LP is fake, Twitter and a spokesman for the news and financial data provider said on Tuesday.
Oracle Corporation (NYSE:ORCL) shares fell -0.05% in last trading session and ended the day at $40.78. ORCL Gross Margin is 80.30% and its return on assets is 11.90%. Oracle Corporation (NYSE:ORCL) quarterly performance is -4.21%. Oracle Corp. (NYSE:ORCL) said that On July 9, 2015, a federal court dismissed Rimini Street and Seth Ravin’s claim that Oracle engaged in “copyright misuse” through its software licenses.